-
Product Insights
NewSequana Medical NV Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Sequana Medical NV Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Sequana Medical NV (Sequana Medical), formerly NovaShunt AG, is a commercial-stage medical device company that offers automated implantable pump systems to monitor fluid balance within the body. The company designs develop and commercialize alfapump, a fully implantable, programmable, transcutaneously-charged, a battery-powered pump, to manage ascites, which occur as a symptom of advanced liver disease, certain cancers, and congestive heart...
-
Product Insights
NewQuarterly Cereal Bars pricing trends in the United Kingdom
Empower your strategies with our Quarterly Cereal Bars pricing trends in the United Kingdom report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement...
-
Product Insights
NewQuarterly Nuts & Seeds pricing trends in the United Kingdom
Empower your strategies with our Quarterly Nuts & Seeds pricing trends in the United Kingdom report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and...
-
Sector Analysis
Electric Vehicle (EV) Sentiment Analysis – Unveiling Consumer Perceptions of Top 10 Companies for US Market on Reddit
This insightful report provides an extensive brand analysis of the leading electric vehicle companies in the US that have dominated conversations on Reddit in Q4 2023. It scrutinizes the sentiment of discussions related to these companies, offering an understanding of the public perception and positioning of these brands in the market. The analysis includes a look at the most discussed categories, such as pricing, battery technology, charging infrastructure, range, and customer service, that are crucial to the success of electric...
-
Sector Analysis
Automotive Advanced xEV Batteries Market Trends, Sector Overview and Forecast to 2028
Automotive Advanced xEV Batteries Market Report Overview The advanced xEV batteries market size was 26.8 million units in 2023. The market will grow at a CAGR of more than 14% during 2023-2028. There was a fluctuation in demand for essential materials owing to the surge In recent years, there has been a significant increase in the adoption of electric vehicles (EVs) and Hybrid Electric Vehicles (HEVs) across the world. Moreover, governments worldwide are incentivizing automakers and consumers to shift towards...
-
Sector Analysis
NewElectric Vehicles (EV) Market Analysis by Region, Product Type, End-Use Type and Forecast to 2031
Accessing the in-depth insights from the ‘Electric Vehicles’ report can help: Gain a valuable understanding of the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and investments. Identify competitors' capabilities to stay ahead in the market. Identify segments and get an understanding of various stakeholders across different stages of the entire value chain. Anticipate changes in demand and adjust the business development strategies. Identify potential regions and countries for growth opportunities. How is our ‘Electric...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anbenitamab in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anbenitamab in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anbenitamab in Gastric Cancer Drug Details: KN-026 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RNS-60 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RNS-60 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RNS-60 in Amyotrophic Lateral Sclerosis Drug Details: RNS-60 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anbenitamab in Gastroesophageal (GE) Junction Carcinomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anbenitamab in Gastroesophageal (GE) Junction Carcinomas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anbenitamab in Gastroesophageal (GE) Junction Carcinomas Drug Details: KN-026 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Prexigebersen in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Prexigebersen in Refractory Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Prexigebersen in Refractory Acute Myeloid Leukemia Drug Details: Prexigebersen (BP-1001)...